Uveitis Treatment Market

Persistence Market Research has compiled a report that examines the global uveitis treatment market for a six-year forecast period, 2014-2020. The primary objective of this report is to offer an extensive analysis and estimation on all the information related to the market, which comprises of factors that drive growth of the market, factors that inhibit growth of the market, trends, opportunities, and recent development related to the global uveitis treatment market. Quantification of data has been taken into consideration along with provision of quality insights collected directly from the market through discussions with various surgeons, market managers, and product managers. The market analysis is conducted, taking into consideration various factors mentioned previously.

In order to understand and assess various opportunities in the global uveitis treatment market, the report is categorically split on the basis key market dynamics, key segmentation, regional trends and key market players. The global uveitis treatment market is analyzed specifically in terms of region, type of treatment, and product type in this report, and offers an exhaustive data analysis on regarding regulations, market estimations, competitive landscape, and forecast values. All the segments have been analyzed on the basis of various factors and estimates to understand relative contribution of individual segments towards the market growth.

The next section of the report throws light on regional analysis and examines for the global uveitis treatment market. This section of the report analyzes and disseminates information regarding various factors pertaining to the region, which are boosting growth of the market along with various factors that are restraining growth of the global uveitis treatment market. Furthermore, the report highlights regions that are more lucrative market and regions that are fastest growing in the global uveitis treatment market. The last section of the report comprises of leading international players operating in the global uveitis treatment market.

Research Methodology

To deduce the global uveitis treatment market size, the report considers various aspects based on secondary research. Furthermore, key data points such as region-wise split and market split by product type, region, and application type; and qualitative inputs from primary respondents have been incorporated to arrive at appropriate market estimates. The forecast presented in the report assesses the total revenue generated and expected revenue contribution in the global uveitis treatment market.

The report begins with sizing the market in terms of value and volume for the base year, which forms the basis for forecasting how the market is anticipated to take shape in the near future. Given the characteristics of the market, gathered data is triangulated via different analysis based on supply side and demand side drivers and other key dynamics of the global uveitis treatment market. To develop the market forecast, Persistence Market Research has also conducted a factor analysis to understand the impact of various forces/factors on the target market. The report provides forecasts not only in terms of CAGR but also presents a detailed analysis based on key parameters such as Year-on-Year (Y-o-Y) growth to understand market predictability and to identify the right opportunities.

Another key feature of this report is an analysis of the global uveitis treatment market and the corresponding revenue forecast in terms of absolute dollar opportunity, usually overlooked while forecasting the market. However, absolute dollar opportunity is critical in assessing the level of opportunity that a provider can look to achieve, as well as to identify potential resources from a sales perspective in the global uveitis treatment market. Further, to understand key segments in terms of their growth and overall global uveitis treatment market performance, Persistence Market Research has developed a market attractiveness index to help providers identify existing market opportunities in the global uveitis treatment market.

Inflammatory disorders, injuries, autoimmune disorders, and various kinds of surgeries result in uveitis. Intraocular inflammation also refers to uveitis, which is the consequence of swelling in the intermediate layer. Common types of uveitis include panuveitis, posterior uveitis, intermediate uveitis, and anterior uveitis, which could vary in terms of severity such as chronic, acute, and recurrent. Some symptoms regarding uveitis comprise eye pain, red eye, eye floaters, blurry vision, and high sensitivity to light. Treatment for uveitis is conducted based on kind of uveitis issue, which eradicates subdue inflammation, eye pain, controlling damages in tissue, and restoring vision of the uveitis infected patient. While corticosteroid, and topical cyclosporine are two commonly conducted treatments, yet antibiotics, anti-inflammatory medication, and immunosuppressive medications commonly find application in the treatment of uveitis. In 2014, the global market for uveitis treatment market was valued at US$ 539.0 Mn. The global uveitis treatment market is projected to be valued at US$ 822.5 Mn by 2020-end, expanding at a CAGR of 7.3% over the forecast period.

Key Market Dynamics

Treatment for complicated cases of eye disorders is expected to witness an upsurge, owing to the increasing old population, which in turn is boosting demand for various operations for treatment such as anti-inflammatory medications and corticosteroids. Due to such factors, there has been a compelling demand for advanced treatment for uveitis treatment such as corticosteroid, and topical cyclosporine among various other medications available. Into the bargain, factors such as surge in investments regarding research and development of various eye disorders and their treatments, and rising prevalence of eye syndromes are estimated to contribute significantly towards growth of the market in the span of next six years.

Conversely, lack of primary healthcare infrastructure such as clinics and hospitals, unaware section of population regarding various eye disorders such as uveitis, in parallel to absence of health insurance in various developing and developed countries are a few factors inhibiting the growth of the global uveitis treatment market in the upcoming years. A recent trend in the global uveitis treatment market has witnessed a trend of increasing application of inhibitor therapy such as anti-TNF-alpha in the near future. Furthermore, factors such as development of molecules from the new class of treatment of uveitis in parallel with robust product pipeline are estimated to offer various opportunities and boost growth of the global uveitis treatment market during the forecast period.

Segmentation Analysis

On the basis of product type, the global uveitis treatment is classified into Panuveitis, intermediate uveitis, posterior uveitis, and anterior uveitis. Whereas, on the basis of treatment, the global uveitis treatment market is segmented into immunosuppressive medications, antibiotic/antiviral medications, and anti-inflammatory medications.

Furthermore, on the basis of region, the global uveitis treatment market is classified into North America, Europe, Asia, and Rest of the World (ROW). Rising old population, surge in eye-related disorders and uveitis, and increasing investments in the research and development regarding eye-related issues and medications are a few factors, which are projected to rev up growth of the market in the span of next six years. Due to such factors, North America is estimated to retain dominance in the global uveitis treatment market over the forecast period. Additionally, increasing awareness among various sections of the population is further predicted to boost growth of the global uveitis treatment market. China and Japan are projected to witness fastest growth in Asia in parallel to growth in the uveitis treatment market in India, which is estimated to witness an upsurge in growth of the market owing to innumerable cases and surge in old population. Factors such as increasing disposable income and innumerable patients are further projected to support growth of the market in the coming years. 

Key Market Players

Some key player operating in the global uveitis treatment market include XOMA Corporation, pSivida Corp., Alcon, Inc., AbbVie Inc., Allergan, Inc., OpthaliX Inc., Enzo Biochem Inc., Regeneron Pharmaceuticals, Bausch & Lomb Incorporated, and Santen Pharmaceuticals Co., Ltd.

Some of the major players in the uveitis treatment market:

• pSivida Corp.
• XOMA Corporation.
• Alcon, Inc.
• Allergan, Inc.
• AbbVie Inc.
• Enzo Biochem Inc.
• OphthaliX Inc.
• Bausch & Lomb Incorporated.
• Regeneron Pharmaceuticals, Inc.
• Santen Pharmaceutical Co., Ltd.
• Other.

These key market players have been profiled on the basis of attributes such as company overview, recent developments, growth strategies, sustainability, and financial overview.